[PDF][PDF] Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy
RA Pattillo, BD Collier, H Abdel-Dayem… - Journal of Nuclear …, 1995 - Soc Nuclear Med
MATERIALS AND METHODS In vitro enhancement of 32P-CP cytotoxicity by cisplatin was
tested in triplicate in CHOA cell lines (362-1 or FriM) in addition to a fibroblast cell strain. Cell …
tested in triplicate in CHOA cell lines (362-1 or FriM) in addition to a fibroblast cell strain. Cell …
Radioactive chromic phosphate suspension: studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients
JL Currie, F Bagne, C Harris, DL Sullivan, EA Surwit… - Gynecologic …, 1981 - Elsevier
A series of studies in phantoms, dogs, and patients was undertaken to investigate physical
properties of the commercial preparation of radioactive chromic phosphate suspension (32 …
properties of the commercial preparation of radioactive chromic phosphate suspension (32 …
Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
JL Powell, MO Burrell, AB Kirchner - Southern Medical Journal, 1987 - europepmc.org
The use of intraperitoneal radioisotopes in the management of women with ovarian cancer
is controversial. We analyzed the experience with intraperitoneal chromic phosphate P 32 at …
is controversial. We analyzed the experience with intraperitoneal chromic phosphate P 32 at …
Ovarian carcinoma: adjuvant treatment with P-32.
S Reddy, GP Sutton, FB Stehman, NB Hornback… - Radiology, 1987 - pubs.rsna.org
Twenty-eight patients with ovarian carcinoma received 555 MBq of labeled chromic
phosphate (P-32) intraperitoneally. Indications for treatment included a high-grade tumor …
phosphate (P-32) intraperitoneally. Indications for treatment included a high-grade tumor …
Complications from intraperitoneal radioactive phosphorus in ovarian malignancies
YN Bakri, FT Given Jr, WJ Peeples, AB Frazier - Gynecologic oncology, 1985 - Elsevier
A retrospective study of the use of phosphorus-32 in the treatment of 73 cases of ovarian
malignancy to evaluate the safety and morbidity is presented. The surgically confirmed …
malignancy to evaluate the safety and morbidity is presented. The surgically confirmed …
Distribution and tissue dose of intraperitoneally administered radioactive chromic phosphate (32P) in New Zealand white rabbits.
PK Leichner, NB Rosenshein, SA Leibel, SE Order - Radiology, 1980 - pubs.rsna.org
Radiophosphorus (32P) has become the preferred radioisotope for intraperitoneal
radiotherapy in the adjuvant treatment of ovarian cancer. In a study of the distribution and …
radiotherapy in the adjuvant treatment of ovarian cancer. In a study of the distribution and …
Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma
MS Fiver, SB Lele, S Bakshi… - American journal of …, 1988 - journals.lww.com
Abstract From 1975 to 1982, 25 evaluable patients with FIGO Stage I ovarian cancer were
treated with intraperitoneal chromic phosphate (32 P). All patients underwent total …
treated with intraperitoneal chromic phosphate (32 P). All patients underwent total …
Intraperitoneal distribution of 32p-chromic phosphate suspension in the dog
HH Tewfik, H Gruber, FA Tewfik, SG Lifshitz - International Journal of …, 1979 - Elsevier
Intraperitoneal administration of radioactive chromic phosphate suspension is receiving
renewed attention as a therapeutic treatment to limit metastatic dissemination of ovarian …
renewed attention as a therapeutic treatment to limit metastatic dissemination of ovarian …
Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications
LA Walton, A Yadusky, L Rubinstein - International Journal of Radiation …, 1991 - Elsevier
Intraperitoneal radioactive chromic phosphate was administered to 69 patients with Stage I
and II ovarian carcinoma who had undergone comprehensive surgical staging. Intestinal …
and II ovarian carcinoma who had undergone comprehensive surgical staging. Intestinal …
Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits
ME Potter, EE Partridge, HM Shingleton, SJ Soong… - Gynecologic …, 1989 - Elsevier
Abstract Between March 1977 and December 1985, 59 patients were treated with
intraperitoneal chromic phosphate at The University of Alabama Birmingham Hospitals and …
intraperitoneal chromic phosphate at The University of Alabama Birmingham Hospitals and …